Page values for "Alpelisib"
Jump to navigation
Jump to search
"_pageData" values
1 row is stored for this page| Field | Field type | Value |
|---|---|---|
| _pageID | Integer | 853,657 |
| _pageName | Page | Alpelisib |
| _pageTitle | String | Alpelisib |
| _pageNamespace | Integer | 0 |
"definitions" values
1 row is stored for this page| Field | Field type | Value |
|---|---|---|
| Term | Page | Alpelisib |
| Short_definition | String | Alpelisib (AL-peh-LIH-sib) A drug used with fulvestrant to treat postmenopausal women and men with hormone receptor-positive, HER2-negative breast cancer that is advanced or has spread and has a mutation (change) in the breast cancerPIK3CAGen. It is used in patients whose cancer has gotten worse dur |
| Type | Page | Cancer terms |
| Specialty | Page | Oncology |
| Language | Page | English |
| Source | Page | NCI |
| Comments | String |